Andere Kunden interessierten sich auch für
![Preparation & Evaluation of Fexofenadine HCL Lozenges by Jaggery]( "Preparation & Evaluation of Fexofenadine HCL Lozenges by Jaggery")
Preparation & Evaluation of Fexofenadine HCL Lozenges by Jaggery23,99 €![Estimation of acebrophylline,fexofenadine hcl and montelukast sodium]( "Estimation of acebrophylline,fexofenadine hcl and montelukast sodium")
Estimation of acebrophylline,fexofenadine hcl and montelukast sodium33,99 €![Formulation and Development of Dispersible Tablet and Dry Syrup]( "Formulation and Development of Dispersible Tablet and Dry Syrup")
Formulation and Development of Dispersible Tablet and Dry Syrup40,99 €![Stima di acebrofilina, fexofenadina hcl e montelukast sodico]( "Stima di acebrofilina, fexofenadina hcl e montelukast sodico")
Stima di acebrofilina, fexofenadina hcl e montelukast sodico33,99 €![Ocenka acebrofillina, fexofenadina hcl i montelukasta natriq]( "Ocenka acebrofillina, fexofenadina hcl i montelukasta natriq")
Ocenka acebrofillina, fexofenadina hcl i montelukasta natriq13,99 €![Estimativa da acebrofilina, da fexofenadina hcl e do montelucaste de sódio]( "Estimativa da acebrofilina, da fexofenadina hcl e do montelucaste de sódio")
Estimativa da acebrofilina, da fexofenadina hcl e do montelucaste de sódio33,99 €![Estimation de l'acébrophylline, de la fexofénadine hcl et du montélukast sodique]( "Estimation de l'acébrophylline, de la fexofénadine hcl et du montélukast sodique")
Estimation de l'acébrophylline, de la fexofénadine hcl et du montélukast sodique33,99 €
The purpose of this research was to formulate tasteless complexes of Fexofenadine Hydrochloride with Kyron-134 and to formulate tasteless complex into fast-Dispersible tablets (FDT) for the treatment of allergic rhinitis & chronic idiopathic urticaria. Drug release from FDT in salivary pH was insufficient to impart bitter taste. Complete drug release was observed at gastric pH. The studies indicate that the formulation was taste masked drug can be formulated in to FDT with view to enhance patient compliance & to obtain faster onset action of the drug which would be advantageous in comparison to the currently available conventional forms. Formulations D-5 was found to be palatable with in vitro disintegration time of 20 s Dissolution studies showed complete release of D-5 within 30 min.